| Trial Identifier: | 9766-CL-0107 |
| Sponsor: | Astellas Pharma Global Development, Inc. |
| Start Date: | August 2019 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | December 2022 |
| Condition: | Infections - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Belgium | Gent, Belgium, 9000 |
| Belgium | Leuven, Belgium, 3000 |
| Spain | Barcelona, Spain, 8035 |
| Spain | Madrid, Spain, 28009 |
| Spain | Madrid, Spain, 28041 |
| United States of America, CA | Los Angeles, CA, United States of America, 90095 |
| United States of America, CA | Los Angeles, CA, United States of America, 90027 |
| United States of America, CA | Orange, CA, United States of America, 92868 |
| United States of America, DC | Washington, DC, United States of America, 20010 |
| United States of America, IL | Chicago, IL, United States of America, 60611 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company